Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: August 2023

MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS), Davidson Technologies Showcase National Defense Solutions at Space and Missile Defense Symposium

Posted on August 7, 2023 by MissionIR

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services, is collaborating with Davidson Technologies Inc. to create innovative new solutions to complex problems in the defense and aerospace sectors. Davidson Technologies is a technology services company … Continue reading →

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) to Host 2Q Conference Call and Webcast

Posted on August 7, 2023 by MissionIR

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has announced plans to hold its Second Quarter Town Hall Update to share current events and 2023 financial highlights following the filing of … Continue reading →

Posted in Knightscope Inc. KSCP | Leave a comment

MissionIRNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Helping to Efficiently Move Commerce with Fr8App Solution

Posted on August 7, 2023 by MissionIR

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a supply chain innovator, recently welcomed an extensive new pool of truck drivers working within the United States-Mexico-Canada Agreement (“USMCA”) trade area, expanding the reach of its platform and increasing the ability of commercial freight … Continue reading →

Posted in Freight Technologies Inc. FRGT | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Distinguished with Unique Capabilities

Posted on August 7, 2023 by MissionIR

CNS Pharmaceuticals (NASDAQ: CNSP), a Texas-based cancer drug innovator, is focused on advancing its potentially pivotal clinical trial to track the effectiveness of drug candidate Berubicin in treating glioblastoma (“GBM”) brain cancers. Berubicin has already produced one patient with over … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Equips Users with Scalable Access to Cashless Alternatives Amid Boom in Digital Payments

Posted on August 7, 2023 by MissionIR

Fintech Ecosystem Development (NASDAQ: FEXD), a special purpose acquisition company (“SPAC”), is focused on the changing consumer landscape and how digital payments are shaping the way people transact. In response, the company is pushing for the creation and proliferation of … Continue reading →

Posted in Fintech Ecosystem Development Corp. FEXD | Leave a comment

D-Wave Quantum Inc. (NYSE: QBTS) Announces Collaboration with VINCI Energies and QuantumBasel to Develop Quantum-Hybrid Applications for Industrial Construction

Posted on August 7, 2023 by MissionIR

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services, focused on delivering customer value via practical quantum applications, has announced a collaboration with QuantumBasel and VINCI Energies, an accelerator of environmental and digital transition, to explore … Continue reading →

Posted in D-Wave Quantum Inc. QBTS | Leave a comment

MissionIRNewsBreaks – Eloro Resources Ltd. (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) Eyes Remarkable Opportunity to Outline Two World-Class Deposits

Posted on August 4, 2023 by MissionIR

Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mining company, remains on track to publish its inaugural NI 43-101 compliant mineral resource estimate focused around the Santa Barbara High-Grade Zone at its Iska Iska site. Simultaneously, the … Continue reading →

Posted in Eloro Resources Ltd. ELRRF | Leave a comment

MissionIRNewsBreaks – Genprex Inc.’s (NASDAQ: GNPX) Third Fast Track Designation Validates REQORSA(R)’s Potential

Posted on August 4, 2023 by MissionIR

Genprex (NASDAQ: GNPX), a gene therapy company, recently received U.S. FDA Fast Track Designation (“FTD”) for its lead product candidate, REQORSA(R) immunogene therapy, in combination with Tecentriq(R), a cancer immunotherapy treatment developed and sold by Genentech, Inc., in patients with … Continue reading →

Posted in Genprex Inc. GNPX | Leave a comment

MissionIRNewsBreaks – Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Aims to Empower Underserved Populations Around the World

Posted on August 4, 2023 by MissionIR

Fintech Ecosystem Development Corp. (NASDAQ: FEXD), a company formed to develop a global financial technology ecosystem, continues to develop a diverse portfolio of FinTech-related products and services to consumers and businesses in the United States, South Asia, East Asia, Africa, … Continue reading →

Posted in Fintech Ecosystem Development Corp. FEXD | Leave a comment

MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) ASR ‘SAM’ to Play Crucial Security Role at Crocker Park

Posted on August 4, 2023 by MissionIR

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, today announced that Crocker Park – a lifestyle center for shopping, dining, playing and living – deployed a K5 ASR at a city … Continue reading →

Posted in Knightscope Inc. KSCP | Leave a comment